| || |
Prof. Dr. Dirk
Professor of Genetics, Center for Cancer Biology AAB Institute
of Biomedical Sciences, University of Rochester, School of
Medicine and Dentistry.
After studying biology, Prof. Bohmann received his doctorate
in 1986 at the Deutsches Krebsforschungszentrum (German Cancer
Research Center) in Heidelberg. Between 1986 and 1989 he worked
in Prof. Robert Tjian's group at the Department of Biochemistry
of the University of California at Berkeley. From 1989, Prof.
Bohmann was a team leader at the European Molecular Biology
Laboratory and in 1996 was promoted to Senior Scientist at
this institute. In 1997 he qualified as a university lecturer
in the field of molecular biology at the faculty of biology
of the University of Heidelberg and was recently appointed
by the University of Rochester.
Prof. Dr. Wieland Huttner
Manager of the Neurobiology Department at the Interdisciplinary
Center for Neurosciences (IZN) at the University of Heidelberg
and director at the Max Planck Institute for Molecular Cellular
Biology and Genetics in Dresden.
Between 1976 and 1980, Prof. Huttner initially worked as a
post-doctoral fellow at the Max Planck Institute for Experimental
Medicine, then as a post-doctoral fellow and research associate
in Prof. Paul Greengard’s team at Yale University School
of Medicine, New Haven (CT), in the Department of Pharmacology.
Between 1981 and 1985, Prof. Huttner was employed as a junior
team leader in the Neurochemistry Department at the Max Planck
Institute for Psychiatry in Martinsried/Munich. Between 1985
and 1990 he was a team leader at the European Molecular Biology
Laboratory in Heidelberg, from where he was appointed in 1991
as the head of the Institute for Neurobiology at the University
of Heidelberg. Prof. Huttner is one of managing directors
of the newly formed Max Planck Institute for Molecular Cellular
Biology and Genetics in Dresden.
Prof. Dr. Hans-Jürgen Quadbeck-Seeger
Former member of the executive board of BASF AG.
Prof. Quadbeck-Seeger studied chemistry at Munich University
where he also received his doctorate. In 1985 he was appointed
as chairman of the executive board of KNOLL AG and became
responsible for the management of the pharmaceutical division
of BASF AG. Between 1990 and 1997, Prof. Quadbeck-Seeger was
a member of the executive board of BASF AG, in charge of corporate
research. Since 1996, he has been a member of the senate of
the Max Planck Society.
Prof. Dr. Gert Riethmüller
Executive board of the Institute for Immunology of Ludwig
Maximilian University, Munich
After studying medicine and following a post-doctoral period
at well-known universities in Europe and America, Prof. Riethmüller
qualified in 1971 as a university lecturer at Tübingen
University, where he became head of the Immunology and Experimental
Surgery Department. In 1977 he became professor for Immunology
of Ludwig Maximilian University in Munich, of which he is
the director to date. Since 1979 he has also been the head
of the Tumor Center of Munich at the Institute of University.
The list of his awards is long; the most important of these
include the Gerhard-Domagk prize for Cancer Research, the
Meyenburg prize of the Deutsches Krebsforschungszentrum (German
Cancer Research Center) in Heidelberg and the honorary doctorate
of the medical faculty of Greifswald University and of Hannover
Medical College. Prof. Riethmüller is a member of the
advisory boards of numerous domestic and foreign research
centers, foundations and institutes. He is highly recognized
internationally for the development of monoclonal antibodies
and their everyday clinical use, for example, in rheumatoid
arthritis and other auto-immune diseases. He has made a decisive
contribution to immune therapy and especially to the antibody
therapy of cancer diseases.
Prof. Dr. Dr. h.c. Thomas Schreckenbach
Former general partner and member of the executive board of
Prof. Schreckenbach studied chemistry at Munich University
and received his doctorate there. Between 1979 and 1986 he
was the head of a working group of the "Membrane Chemistry"
Department at the Max Planck Institute for Biochemistry in
Martinsried. In 1986, Prof. Schreckenbach joined E. Merck,
Darmstadt, as head of biochemical research. There he was manager
of central chemical research between 1987 and 1988, manager
of the pigments division between 1989 and 1990 and in 1991
was appointed to the executive management. He was responsible
for the division of specialty chemicals, research chemistry,
central research services, analysis and scientific information.
Prof. Dr. Dr. h.c. Günter Stock
Former member of the executive board of Schering AG.
Prof. Stock studied medicine at Heidelberg University, qualified
as a university lecturer in 1978 for the Faculty of Physiology
and received a professorship for the Vegetative Physiology
Faculty in 1980. In 1983 he joined Schering AG as manager
of the main department of Heart/Cardiovascular Pharmacology
and assumed management of the Institute for Pharmacology of
Schering in 1987. In 1989 he was appointed to the executive
board of Schering AG and was in charge of the corporate research
and development function and supervising the strategic business
units for the Latin America region.
| || || |